Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

612
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
612
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

246
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

377
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
377
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

351
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
351
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

601
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment.

Heart (British Cardiac Society)·2026
Same author

From Mechanics to Mitochondria: Dyssynchronous Heart Failure as an Energetic Disease.

European journal of heart failure·2026
Same author

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Point-of-care testing for pre-hospital stratification after out-of-hospital cardiac arrest: the RAPID-MIRACLE study.

European heart journal. Acute cardiovascular care·2026
Same author

COVID-19 and elevated coronary thrombus burden - a persistent risk even after recovery?

Cardiology journal·2026
Same author

Prospective Validation of the MIRACLE<sub>2</sub> Score for Early Neurological Stratification After Out-of-Hospital Cardiac-Arrest: The GLOBAL-MIRACLE Registry.

Circulation. Cardiovascular interventions·2026

Related Experiment Video

Updated: Dec 27, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K

Acute heart failure.

Mattia Arrigo1, Mariell Jessup2, Wilfried Mullens3,4

  • 1Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.

Nature Reviews. Disease Primers
|March 7, 2020
PubMed
Summary
This summary is machine-generated.

Acute heart failure (AHF) involves new or worsening heart failure symptoms, often due to congestion. Current treatments are symptomatic, leading to high mortality, highlighting a need for personalized management strategies.

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

Related Experiment Videos

Last Updated: Dec 27, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Science

Background:

  • Acute heart failure (AHF) is characterized by new onset or worsening heart failure symptoms, primarily systemic congestion.
  • AHF arises from underlying cardiac dysfunction, precipitated by various factors, or de novo cardiac events like acute coronary syndromes.
  • The heterogeneous pathophysiology of AHF, involving ventricular dysfunction and congestion, leads to organ hypoperfusion.

Purpose of the Study:

  • To address the limitations of current symptomatic treatments for AHF.
  • To highlight the unmet need for individualized in-hospital management of AHF.
  • To emphasize the importance of targeting causative factors and post-discharge care for improved long-term outcomes.

Main Methods:

  • Review of AHF pathophysiology and current treatment paradigms.
  • Analysis of factors contributing to AHF presentation and heterogeneity.
  • Evaluation of treatment outcomes, including mortality and readmission rates.

Main Results:

  • AHF presents with diverse underlying causes and precipitating factors, resulting in heterogeneous pathophysiology.
  • Current AHF management is primarily symptomatic, focusing on decongestion.
  • Despite treatment, AHF is associated with high mortality and hospital readmission rates.

Conclusions:

  • There is a critical need for personalized AHF management strategies.
  • Treatments should address causative factors and extend beyond hospital discharge.
  • Individualized care is essential to improve long-term outcomes and reduce AHF-related mortality and morbidity.